Analysis Of Drug Use Patterns Towards Total Costs Hypertensive Inpatients at Panembahan Senopati Hospital
Analisis Pola Penggunakan Obat Terhadap Biaya Total Pasien Hipertensi Rawat Inap di RSUD Panembahan Senopati
Keywords:
INA-CBGs, Hypertension, Medication, Costs, Inpatients
Abstract
The National Health Insurance System imposes health service tariffs by way of the INA-CBGS tariff. Payment using the INA-CBGS system is based on the diagnosis issued to the patient. The difference in costs between class 1, 2, and 3 patients in the same code is the cost of accommodation. This study aims to compare the cost of inpatient treatment of hypertensive patients between class 1, 2, and 3 patients and to determine patterns of drug use. The research data was taken retrospectively from hospital financial data and patient medical records. The study was conducted for 10 months (October 2016 to July 2017) with a total of 53 patients who met the inclusion criteria. The results showed that the total hospital costs exceeded the INA-CBGs claim rates. The cost of using drugs per day for class 1 is Rp. 166,550, class 2 Rp. 161,659 and class 3 Rp. 99,285 with statistical test results obtained p value> 0.05. The pattern of drug use in patients class 1 (generic = 55.4%, patent 44.5%), class 2 (generic = 56%, patent 44%), and class 3 (generic = 60%, patent = 40%). The mean drug items received by class 1 patients = 12.16 items, class 2 = 12.75 items, and class 3 = 9.45 items. Based on the Post Hoc test, the results showed that the average drug prescribed for class 3 inpatient hypertension was significantly different from class 1 and 2 patients.References
1. Dumai PK. Percepatan UHC di Kota Dumai, Dinkes Dumai Gelar Penandatanganan Komitmen Bersama Terkait Riau Menuju Jaminan Kesehatan Semesta. Website Resmi Pemerintah Kota Dumai. 2022;
2. Susanti. Kualitas Pelayanan Pasien Badan Penyelenggara Jaminan Sosial di Pusat Kesehatan Masyarakat Biromaru Kabupaten Sigi. e J Katalogis. 2016;4(3):47–57.
3. BPJS kesehatan. Tata Kelola yang Baik ( Good Governance ) BPJS Kesehatan. Jakarta; 2014.
4. BPJS Kesehatan. Perubahan Tarif INA- CBGs. Jakarta; 2014.
5. Dewi MW, Sulistyani D. Perbandingan Premi Asuransi Kesehatan Peserta Bpjs Badan Usaha Dengan Asuransi Kesehatan Swasta. J Akunt Dan Pajak. 2017;16(01).
6. Minister of Health. Regulation of the Minister of Health Number 73 of 2016 concerning Pharmaceutical Service Standards in Pharmacies. 2016. 123–130 p.
7. Indonesian Health Ministry. Regulation of the Minister of Health Number 52 of 2016 concerning Health Service Tariff Standards in the Implementation of the Health Insurance Program. Jakarta; 2016.
8. Presiden Republik Indonesia. Peraturan Presiden Republik Indonesia Nomor 12 Tahun 2013 Tentang Jaminan Kesehatan. Jakarta; 2013.
9. Khairunnisa F, Yuniarni U, Lestari F, Firmansyah D, Farmasi P, Matematika F, et al. Evaluasi Penggunaan Jumlah Obat Non Formularium Nasional pada Pasien BPJS Rawat Jalan di Satu Rumah Sakit Umum Swasta Evaluation of Non National Formulary Drug Use in Outpatient BPJS at A Public Private General Hospital. Spes Semin Penelit Sivitas Akad Unisba. 2016;378:427–32.
10. Suharmiati S, Handayani L, Roosihermiatie B. Analisis Biaya Obat Unit Rawat Jalan pada Rumah Sakit Badan Layanan Umum (BLU)/ Badan Layanan Umum Daerah (BLUD) di Indonesia. J Kefarmasian Indones. 2019;126–39.
11. Indonesian Health Ministry. Minister of Health Regulation Number 27 of 2014 concerning Technical Guidelines for the Indonesian Case Base Groups System. Jakarta; 2014.
12. Arum YTG. Hipertensi pada Penduduk Usia Produktif (15-64 Tahun). Higeia J Public Heal Res Dev. 2019;1(3):84–94.
13. Akbar F, Nur H, Humaerah UI, Keperawatan A, Wonomulyo Y, Gatot Subroto J. Karakteristik Hipertensi Pada Lanjut Usia Di Desa Buku (Characteristics of Hypertension in the Elderly). Jwk. 2020;5(2):2548–4702.
14. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2013 update: A Report from the American Heart Association. Circulation. 2013;127(1).
15. Hannan M, Yasin Z, Hidayat S. Pengaruh Karakteristik Perokok Aktif Pada Penderita Hipertensi Di Upt Puskesmas Dasuk. Wiraraja Med. 2018;7(1):12–9.
16. Statistics Indonesia. Indonesia - Survei Sosial Ekonomi Nasional 2001. Badan Pus Stat. 2001;1–112.
17. Nuraini B. Risk Factors of Hypertension. J Major. 2015;4(5):10–9.
18. Tanner AE, Ranti L, Lolo WA. Evaluasi Pelaksanaan Pelayanan Resep Obat Generik Pada Pasien Bpjs Rawat Jalan Di Rsup. Prof. Dr. R.D. Kandou Manado Periode Januari-Juni 2014. Pharmacon. 2015;4(4):58–64.
19. Anggriani Y, Sarnianto P, Aisyah S, Pontoan J. Trend Price Analysis of Drug Before and After the Implementation of E-catalogue at the Hospital. J Manaj DAN PELAYANAN Farm (Journal Manag Pharm Pract. 2019;9(1):1.
20. Johnston A, Stafylas P, Stergiou GS. Effectiveness , safety and cost of drug substitution in hypertension. Br J Clin Pharmacol. 2010;
21. Jabani AS, Kusnan A, B IMC. Prevalensi dan Faktor Risiko Hipertensi Derajat 2 Di Wilayah Kerja Puskesmas Poasia Kota Kendari. Nurs Updat J Ilm Ilmu Keperawatan P-ISSN 2085-5931 e-ISSN 2623-2871 [Internet]. 2021;12(4):31–42. Available from: https://stikes-nhm.e-journal.id/NU/article/view/494
22. Yusuf F. Studi Perbandingan Obat Generik dan Obat Dengan Nama Dagang. J Farmanesia [Internet]. 2016;9(2):10. Available from: https://www.infodesign.org.br/infodesign/article/view/355%0Ahttp://www.abergo.org.br/revista/index.php/ae/article/view/731%0Ahttp://www.abergo.org.br/revista/index.php/ae/article/view/269%0Ahttp://www.abergo.org.br/revista/index.php/ae/article/view/106
23. W Himmel , A Simmenroth-Nayda, W Niebling, T Ledig, RD Jansen MK. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43:472–9.
24. Manisha Das, Supriyo Choudhury, Somnath Maity, Avijit Hazra, Tirthankar Pradhan, Aishee Pal RKR. Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department. J Nat Sci Biol Med. 2017;8(1): 26–3.
2. Susanti. Kualitas Pelayanan Pasien Badan Penyelenggara Jaminan Sosial di Pusat Kesehatan Masyarakat Biromaru Kabupaten Sigi. e J Katalogis. 2016;4(3):47–57.
3. BPJS kesehatan. Tata Kelola yang Baik ( Good Governance ) BPJS Kesehatan. Jakarta; 2014.
4. BPJS Kesehatan. Perubahan Tarif INA- CBGs. Jakarta; 2014.
5. Dewi MW, Sulistyani D. Perbandingan Premi Asuransi Kesehatan Peserta Bpjs Badan Usaha Dengan Asuransi Kesehatan Swasta. J Akunt Dan Pajak. 2017;16(01).
6. Minister of Health. Regulation of the Minister of Health Number 73 of 2016 concerning Pharmaceutical Service Standards in Pharmacies. 2016. 123–130 p.
7. Indonesian Health Ministry. Regulation of the Minister of Health Number 52 of 2016 concerning Health Service Tariff Standards in the Implementation of the Health Insurance Program. Jakarta; 2016.
8. Presiden Republik Indonesia. Peraturan Presiden Republik Indonesia Nomor 12 Tahun 2013 Tentang Jaminan Kesehatan. Jakarta; 2013.
9. Khairunnisa F, Yuniarni U, Lestari F, Firmansyah D, Farmasi P, Matematika F, et al. Evaluasi Penggunaan Jumlah Obat Non Formularium Nasional pada Pasien BPJS Rawat Jalan di Satu Rumah Sakit Umum Swasta Evaluation of Non National Formulary Drug Use in Outpatient BPJS at A Public Private General Hospital. Spes Semin Penelit Sivitas Akad Unisba. 2016;378:427–32.
10. Suharmiati S, Handayani L, Roosihermiatie B. Analisis Biaya Obat Unit Rawat Jalan pada Rumah Sakit Badan Layanan Umum (BLU)/ Badan Layanan Umum Daerah (BLUD) di Indonesia. J Kefarmasian Indones. 2019;126–39.
11. Indonesian Health Ministry. Minister of Health Regulation Number 27 of 2014 concerning Technical Guidelines for the Indonesian Case Base Groups System. Jakarta; 2014.
12. Arum YTG. Hipertensi pada Penduduk Usia Produktif (15-64 Tahun). Higeia J Public Heal Res Dev. 2019;1(3):84–94.
13. Akbar F, Nur H, Humaerah UI, Keperawatan A, Wonomulyo Y, Gatot Subroto J. Karakteristik Hipertensi Pada Lanjut Usia Di Desa Buku (Characteristics of Hypertension in the Elderly). Jwk. 2020;5(2):2548–4702.
14. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2013 update: A Report from the American Heart Association. Circulation. 2013;127(1).
15. Hannan M, Yasin Z, Hidayat S. Pengaruh Karakteristik Perokok Aktif Pada Penderita Hipertensi Di Upt Puskesmas Dasuk. Wiraraja Med. 2018;7(1):12–9.
16. Statistics Indonesia. Indonesia - Survei Sosial Ekonomi Nasional 2001. Badan Pus Stat. 2001;1–112.
17. Nuraini B. Risk Factors of Hypertension. J Major. 2015;4(5):10–9.
18. Tanner AE, Ranti L, Lolo WA. Evaluasi Pelaksanaan Pelayanan Resep Obat Generik Pada Pasien Bpjs Rawat Jalan Di Rsup. Prof. Dr. R.D. Kandou Manado Periode Januari-Juni 2014. Pharmacon. 2015;4(4):58–64.
19. Anggriani Y, Sarnianto P, Aisyah S, Pontoan J. Trend Price Analysis of Drug Before and After the Implementation of E-catalogue at the Hospital. J Manaj DAN PELAYANAN Farm (Journal Manag Pharm Pract. 2019;9(1):1.
20. Johnston A, Stafylas P, Stergiou GS. Effectiveness , safety and cost of drug substitution in hypertension. Br J Clin Pharmacol. 2010;
21. Jabani AS, Kusnan A, B IMC. Prevalensi dan Faktor Risiko Hipertensi Derajat 2 Di Wilayah Kerja Puskesmas Poasia Kota Kendari. Nurs Updat J Ilm Ilmu Keperawatan P-ISSN 2085-5931 e-ISSN 2623-2871 [Internet]. 2021;12(4):31–42. Available from: https://stikes-nhm.e-journal.id/NU/article/view/494
22. Yusuf F. Studi Perbandingan Obat Generik dan Obat Dengan Nama Dagang. J Farmanesia [Internet]. 2016;9(2):10. Available from: https://www.infodesign.org.br/infodesign/article/view/355%0Ahttp://www.abergo.org.br/revista/index.php/ae/article/view/731%0Ahttp://www.abergo.org.br/revista/index.php/ae/article/view/269%0Ahttp://www.abergo.org.br/revista/index.php/ae/article/view/106
23. W Himmel , A Simmenroth-Nayda, W Niebling, T Ledig, RD Jansen MK. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43:472–9.
24. Manisha Das, Supriyo Choudhury, Somnath Maity, Avijit Hazra, Tirthankar Pradhan, Aishee Pal RKR. Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department. J Nat Sci Biol Med. 2017;8(1): 26–3.
Published
2023-07-14
How to Cite
Febri Nilansari, A. (2023). Analysis Of Drug Use Patterns Towards Total Costs Hypertensive Inpatients at Panembahan Senopati Hospital: Analisis Pola Penggunakan Obat Terhadap Biaya Total Pasien Hipertensi Rawat Inap di RSUD Panembahan Senopati. Journal Pharmasci (Journal of Pharmacy and Science), 8(2), 89-96. https://doi.org/10.53342/pharmasci.v8i2.349
Section
Articles
Copyright (c) 2023 Anis
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
